Dennis Black, PhD

Title(s)Professor, Epidemiology & Biostatistics
SchoolSchool of Medicine
Address550 16th. Street, #2733
San Francisco CA 94158
Phone415-514-8159
vCardDownload vCard

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Regulatory qualification for DXA bone mineral density as a surrogate endpoint for fracture risk in osteoporosis trials
    NIH U01FD006881Sep 1, 2019 - Aug 31, 2020
    Role: Principal Investigator
    Cellular Mechanisms of PTH1R Activation with Osteoporosis Treatments
    NIH R21AR071739Apr 5, 2017 - Mar 31, 2019
    Role: Co-Principal Investigator
    UCSF Core Center for Musculoskeletal Biology and Medicine
    NIH P30AR066262Jul 1, 2014 - Mar 31, 2020
    Role: Co-Investigator
    Trial Of Late SURFactant (TOLSURF) to Prevent BPD-Data Coordinating Center
    NIH U01HL094355Sep 15, 2009 - May 31, 2016
    Role: Principal Investigator
    PTH and ALDENRONATE COMBINATION TREATMENT OSTEOPOROSIS-264002245
    NIH/NIAMS N01AR002245Oct 28, 2004
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Anti-fracture treatment efficacy by age. J Bone Miner Res. 2024 Mar 19. Schini M, Vilaca T, Vittinghoff E, Lui LY, Ewing SK, Thompson A, Bauer DC, Bouxsein ML, Black DM, Eastell R. PMID: 38501786.
      View in: PubMed   Mentions:    Fields:    
    2. Predictors of response in PROMIS-global in a chronic low back pain specialty clinic: STarTBack and chronic overlapping pain conditions. J Back Musculoskelet Rehabil. 2024 Feb 01. Zheng P, Ewing S, Tang A, Black D, Hue T, Lotz J, Peterson T, Torres-Espin A, O'Neill C. PMID: 38427463.
      View in: PubMed   Mentions:    Fields:    
    3. Bisphosphonate Use and Risk of Atypical Femoral Fractures: A Danish Case Cohort Study with Blinded Radiographic Review. J Clin Endocrinol Metab. 2024 Jan 10. Bauer DC, Black DM, Dell R, Fan B, Smith CD, Ernst MT, Jurik AG, Frøkjær JB, Boesen M, Vittinghoff E, Abrahamsen B. PMID: 38198798.
      View in: PubMed   Mentions:    Fields:    
    4. Intestinal Calcium Absorption Decreases After Laparoscopic Sleeve Gastrectomy Despite Optimization of Vitamin D Status. J Clin Endocrinol Metab. 2023 01 17; 108(2):351-360. Wu KC, Cao S, Weaver CM, King NJ, Patel S, Kim TY, Black DM, Kingman H, Shafer MM, Rogers SJ, Stewart L, Carter JT, Posselt AM, Schafer AL. PMID: 36196648; PMCID: PMC10091486.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    5. Diabetes Mellitus and the Benefit of Antiresorptive Therapy on Fracture Risk. J Bone Miner Res. 2022 11; 37(11):2121-2131. Eastell R, Vittinghoff E, Lui LY, Ewing SK, Schwartz AV, Bauer DC, Black DM, Bouxsein ML. PMID: 36065588; PMCID: PMC10092457.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    6. Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults. N Engl J Med. 2022 07 28; 387(4):299-309. LeBoff MS, Chou SH, Ratliff KA, Cook NR, Khurana B, Kim E, Cawthon PM, Bauer DC, Black D, Gallagher JC, Lee IM, Buring JE, Manson JE. PMID: 35939577; PMCID: PMC9716639.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    7. Coronary artery calcium and bone mineral density by serial CTA: Does menopausal hormone therapy modify the association? Clin Imaging. 2022 Oct; 90:26-31. Cherukuri L, Kinninger A, Birudaraju D, Jayawardena E, Manubolu VS, Brinton EA, Black D, Miller V, Kearns AE, Manson JE, Budoff MJ, Roy SK. PMID: 35908457.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Prebiotic to Improve Calcium Absorption in Postmenopausal Women After Gastric Bypass: A Randomized Controlled Trial. J Clin Endocrinol Metab. 2022 03 24; 107(4):1053-1064. Wu KC, Cao S, Weaver CM, King NJ, Patel S, Kingman H, Sellmeyer DE, McCauley K, Li D, Lynch SV, Kim TY, Black DM, Shafer MM, Özçam M, Lin DL, Rogers SJ, Stewart L, Carter JT, Posselt AM, Schafer AL. PMID: 34888663; PMCID: PMC8947782.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Low cumulative disease activity is associated with higher bone mineral density in a majority Latinx and Asian US rheumatoid arthritis cohort. Semin Arthritis Rheum. 2022 04; 53:151972. Wysham KD, Shofer J, Lui G, Trupin L, Andrews JS, Black DM, Graf J, Shoback DM, Katz PP. PMID: 35152085; PMCID: PMC8963706.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. A Perspective on Postmenopausal Bone Loss with Aging. J Bone Miner Res. 2022 02; 37(2):171-172. Wu KC, Black DM. PMID: 34985153.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Bisphosphonates and the risk of atypical femur fractures. Bone. 2022 03; 156:116297. Black DM, Condra K, Adams AL, Eastell R. PMID: 34920168.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    12. Outcomes post fragility fracture among members of an integrated healthcare organization. Osteoporos Int. 2022 Apr; 33(4):783-790. Adams AL, Ryan DS, Li BH, Williams SA, Wang Y, Weiss RJ, Black DM. PMID: 34686906; PMCID: PMC8930877.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    13. The Interaction of Acute-Phase Reaction and Efficacy for Osteoporosis After Zoledronic Acid: HORIZON Pivotal Fracture Trial. J Bone Miner Res. 2022 01; 37(1):21-28. Black DM, Reid IR, Napoli N, Ewing SK, Shiraki M, Nakamura T, Takeuchi Y, Schafer AL, Kim TY, Cauley JA. PMID: 34585443; PMCID: PMC10441037.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    14. Validation of the Surrogate Threshold Effect for Change in Bone Mineral Density as a Surrogate Endpoint for Fracture Outcomes: The FNIH-ASBMR SABRE Project. J Bone Miner Res. 2022 01; 37(1):29-35. Eastell R, Vittinghoff E, Lui LY, McCulloch CE, Pavo I, Chines A, Khosla S, Cauley JA, Mitlak B, Bauer DC, Bouxsein M, Black DM. PMID: 34490915; PMCID: PMC9291617.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    15. A novel effervescent formulation of oral weekly alendronate (70 mg) improves persistence compared to alendronate tablets in post-menopausal women with osteoporosis. Aging Clin Exp Res. 2021 Sep; 33(9):2529-2537. Giusti A, Bianchi G, Barone A, Black DM. PMID: 33449337.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    16. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. Reply. N Engl J Med. 2020 11 26; 383(22):2189-2190. Black DM, Eastell R, Adams AL. PMID: 33252883.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. Bone mineral density as a surrogate biomarker for fracture risk reduction - Authors' reply. Lancet Diabetes Endocrinol. 2020 11; 8(11):876. Black DM, Bouxsein ML, Bauer DC, Eastell R. PMID: 33065056.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Treatment-Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Antiresorptive Drugs: Proportion of Treatment Effect Explained. J Bone Miner Res. 2021 02; 36(2):236-243. Eastell R, Black DM, Lui LY, Chines A, Marin F, Khosla S, de Papp AE, Cauley JA, Mitlak B, McCulloch CE, Vittinghoff E, Bauer DC, Foundation for the National Institutes of Health (FNIH) Bone Quality Project. PMID: 32916023.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    19. Bone Turnover Markers Do Not Predict Fracture Risk in Type 2 Diabetes. J Bone Miner Res. 2020 12; 35(12):2363-2371. Napoli N, Conte C, Eastell R, Ewing SK, Bauer DC, Strotmeyer ES, Black DM, Samelson EJ, Vittinghoff E, Schwartz AV. PMID: 32717111.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    20. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. N Engl J Med. 2020 08 20; 383(8):743-753. Black DM, Geiger EJ, Eastell R, Vittinghoff E, Li BH, Ryan DS, Dell RM, Adams AL. PMID: 32813950; PMCID: PMC9632334.
      View in: PubMed   Mentions: 91     Fields:    Translation:Humans
    21. Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials. Lancet Diabetes Endocrinol. 2020 08; 8(8):672-682. Black DM, Bauer DC, Vittinghoff E, Lui LY, Grauer A, Marin F, Khosla S, de Papp A, Mitlak B, Cauley JA, McCulloch CE, Eastell R, Bouxsein ML, Foundation for the National Institutes of Health Bone Quality Project. PMID: 32707115.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    22. History of alendronate. Bone. 2020 08; 137:115411. Cummings SR, Santora AC, Black DM, Russell RGG. PMID: 32437874.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    23. Zoledronate. Bone. 2020 08; 137:115390. Reid IR, Green JR, Lyles KW, Reid DM, Trechsel U, Hosking DJ, Black DM, Cummings SR, Russell RGG, Eriksen EF. PMID: 32353565.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    24. Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial. Menopause. 2020 03; 27(3):255-262. El Khoudary SR, Venugopal V, Manson JE, Brooks MM, Santoro N, Black DM, Harman M, Naftolin F, Hodis HN, Brinton EA, Miller VM, Taylor HS, Budoff MJ. PMID: 32015261; PMCID: PMC7113029.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update. J Clin Endocrinol Metab. 2020 03 01; 105(3). Shoback D, Rosen CJ, Black DM, Cheung AM, Murad MH, Eastell R. PMID: 32068863.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    26. Now That You Can Get What You Want, Can You Keep What You Need? J Bone Miner Res. 2020 02; 35(2):217-218. Black DM, Sellmeyer DE. PMID: 31845376.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Increases in PYY and uncoupling of bone turnover are associated with loss of bone mass after gastric bypass surgery. Bone. 2020 02; 131:115115. Kim TY, Shoback DM, Black DM, Rogers SJ, Stewart L, Carter JT, Posselt AM, King NJ, Schafer AL. PMID: 31689523; PMCID: PMC6930344.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    28. Impact of Bariatric Surgery on Adipose Tissue and Liver Inflammation in Adolescents with Nonalcoholic Steatohepatitis. J Pediatr. 2020 01; 216:7-9. Black DD. PMID: 31587862.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned? Menopause. 2019 09; 26(9):1071-1084. Miller VM, Naftolin F, Asthana S, Black DM, Brinton EA, Budoff MJ, Cedars MI, Dowling NM, Gleason CE, Hodis HN, Jayachandran M, Kantarci K, Lobo RA, Manson JE, Pal L, Santoro NF, Taylor HS, Harman SM. PMID: 31453973; PMCID: PMC6738629.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    30. Reply to: Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials. J Bone Miner Res. 2019 10; 34(10):1977-1978. Bouxsein ML, Eastell R, Liu LY, Wu LA, de Papp AE, Grauer A, Marin F, Cauley JA, Bauer DC, Black DM, FNIH Bone Quality Project. PMID: 31433861.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    31. Effects of Hormone Therapy on Heart Fat and Coronary Artery Calcification Progression: Secondary Analysis From the KEEPS Trial. J Am Heart Assoc. 2019 08 06; 8(15):e012763. El Khoudary SR, Zhao Q, Venugopal V, Manson JE, Brooks MM, Santoro N, Black DM, Harman SM, Cedars MI, Hopkins PN, Kearns AE, Miller VM, Taylor HS, Budoff MJ. PMID: 31652073; PMCID: PMC6761637.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    32. Effect of Insulin Resistance on BMD and Fracture Risk in Older Adults. J Clin Endocrinol Metab. 2019 08 01; 104(8):3303-3310. Napoli N, Conte C, Pedone C, Strotmeyer ES, Barbour KE, Black DM, Samelson EJ, Schwartz AV. PMID: 30802282; PMCID: PMC6584125.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    33. Non-contrast cardiac CT-based quantitative evaluation of epicardial and intra-thoracic fat in healthy, recently menopausal women: Reproducibility data from the Kronos Early Estrogen Prevention Study. J Cardiovasc Comput Tomogr. 2020 Jan - Feb; 14(1):55-59. Jayawardena E, Li D, Nakanishi R, Dey D, Dailing C, Qureshi A, Dickens B, Hathiramani N, Kim M, Flores F, Kearns AE, Lui LY, Black D, Budoff MJ. PMID: 31078511; PMCID: PMC6829052.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    34. Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019 05 01; 104(5):1595-1622. Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. PMID: 30907953.
      View in: PubMed   Mentions: 209     Fields:    Translation:Humans
    35. Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management. Endocr Rev. 2019 04 01; 40(2):333-368. Black DM, Abrahamsen B, Bouxsein ML, Einhorn T, Napoli N. PMID: 30169557.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    36. Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials. J Bone Miner Res. 2019 04; 34(4):632-642. Bouxsein ML, Eastell R, Lui LY, Wu LA, de Papp AE, Grauer A, Marin F, Cauley JA, Bauer DC, Black DM, FNIH Bone Quality Project. PMID: 30674078.
      View in: PubMed   Mentions: 99     Fields:    Translation:Humans
    37. Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON-PFT Extension I Trials. J Bone Miner Res. 2019 05; 34(5):810-816. Kim TY, Bauer DC, McNabb BL, Schafer AL, Cosman F, Black DM, Eastell R. PMID: 30536713; PMCID: PMC10463267.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    38. Osteoporosis and Hip Fracture Risk From Routine Computed Tomography Scans: The Fracture, Osteoporosis, and CT Utilization Study (FOCUS). J Bone Miner Res. 2018 07; 33(7):1291-1301. Adams AL, Fischer H, Kopperdahl DL, Lee DC, Black DM, Bouxsein ML, Fatemi S, Khosla S, Orwoll ES, Siris ES, Keaveny TM. PMID: 29665068; PMCID: PMC6155990.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    39. Maternal Black Race and Persistent Wheezing Illness in Former Extremely Low Gestational Age Newborns: Secondary Analysis of a Randomized Trial. J Pediatr. 2018 07; 198:201-208.e3. Wai KC, Hibbs AM, Steurer MA, Black DM, Asselin JM, Eichenwald EC, Ballard PL, Ballard RA, Keller RL, Trial of Late Surfactant (TOLSURF) Study Group. PMID: 29627188; PMCID: PMC6019148.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    40. Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture Occur Early and Particularly Impact Postmenopausal Women. J Bone Miner Res. 2018 06; 33(6):975-986. Schafer AL, Kazakia GJ, Vittinghoff E, Stewart L, Rogers SJ, Kim TY, Carter JT, Posselt AM, Pasco C, Shoback DM, Black DM. PMID: 29281126; PMCID: PMC6002877.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    41. Treatment-Related Changes in Bone Turnover and Fracture Risk Reduction in Clinical Trials of Anti-Resorptive Drugs: A Meta-Regression. J Bone Miner Res. 2018 04; 33(4):634-642. Bauer DC, Black DM, Bouxsein ML, Lui LY, Cauley JA, de Papp AE, Grauer A, Khosla S, McCulloch CE, Eastell R, Foundation for the National Institutes of Health (FNIH) Bone Quality Project. PMID: 29318649.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    42. Reply to: Indications of Increased Vertebral Fracture Risk in Patients With Type 2 Diabetes. J Bone Miner Res. 2018 01; 33(1):183. Napoli N, Schwartz AV, Black DM, Osteoporotic Fractures in Men (MrOS) Study Research Group. PMID: 29077237.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Vertebral Fracture Risk in Diabetic Elderly Men: The MrOS Study. J Bone Miner Res. 2018 01; 33(1):63-69. Napoli N, Schwartz AV, Schafer AL, Vittinghoff E, Cawthon PM, Parimi N, Orwoll E, Strotmeyer ES, Hoffman AR, Barrett-Connor E, Black DM, Osteoporotic Fractures in Men (MrOS) Study Research Group. PMID: 28861910; PMCID: PMC6702944.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    44. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS). JAMA Intern Med. 2017 10 01; 177(10):1471-1479. Taylor HS, Tal A, Pal L, Li F, Black DM, Brinton EA, Budoff MJ, Cedars MI, Du W, Hodis HN, Lobo RA, Manson JE, Merriam GR, Miller VM, Naftolin F, Neal-Perry G, Santoro NF, Harman SM. PMID: 28846767; PMCID: PMC5710212.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    45. Evaluating Atypical Features of Femur Fractures: How Change in Radiological Criteria Influenced Incidence and Demography of Atypical Femur Fractures in a Community Setting. J Bone Miner Res. 2017 Nov; 32(11):2304-2314. LeBlanc ES, Rosales AG, Black DM, Genant HK, Dell RM, Friess DM, Boardman DL, Bauer DC, de Papp A, Santora AC, Orwoll ES. PMID: 28731209.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    46. Bone Marrow Fat Changes After Gastric Bypass Surgery Are Associated With Loss of Bone Mass. J Bone Miner Res. 2017 Nov; 32(11):2239-2247. Kim TY, Schwartz AV, Li X, Xu K, Black DM, Petrenko DM, Stewart L, Rogers SJ, Posselt AM, Carter JT, Shoback DM, Schafer AL. PMID: 28791737; PMCID: PMC5685913.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    47. The Ability of a Single BMD and Fracture History Assessment to Predict Fracture Over 25 Years in Postmenopausal Women: The Study of Osteoporotic Fractures. J Bone Miner Res. 2018 03; 33(3):389-395. Black DM, Cauley JA, Wagman R, Ensrud K, Fink HA, Hillier TA, Lui LY, Cummings SR, Schousboe JT, Napoli N. PMID: 28719727; PMCID: PMC6103616.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    48. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study. Menopause. 2017 03; 24(3):238-246. Santoro N, Allshouse A, Neal-Perry G, Pal L, Lobo RA, Naftolin F, Black DM, Brinton EA, Budoff MJ, Cedars MI, Dowling NM, Dunn M, Gleason CE, Hodis HN, Isaac B, Magnani M, Manson JE, Miller VM, Taylor HS, Wharton W, Wolff E, Zepeda V, Harman SM. PMID: 27779568; PMCID: PMC5323337.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    49. Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis: Results of the ACTIVExtend Trial. Mayo Clin Proc. 2017 Feb; 92(2):200-210. Cosman F, Miller PD, Williams GC, Hattersley G, Hu MY, Valter I, Fitzpatrick LA, Riis BJ, Christiansen C, Bilezikian JP, Black D. PMID: 28160873.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    50. The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age. J Pediatr. 2017 04; 183:19-25.e2. Keller RL, Eichenwald EC, Hibbs AM, Rogers EE, Wai KC, Black DM, Ballard PL, Asselin JM, Truog WE, Merrill JD, Mammel MC, Steinhorn RH, Ryan RM, Durand DJ, Bendel CM, Bendel-Stenzel EM, Courtney SE, Dhanireddy R, Hudak ML, Koch FR, Mayock DE, McKay VJ, Helderman J, Porta NF, Wadhawan R, Palermo L, Ballard RA, TOLSURF Study Group. PMID: 28100402; PMCID: PMC5367937.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    51. Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis. J Bone Miner Res. 2017 01; 32(1):3-10. Cummings SR, Cosman F, Lewiecki EM, Schousboe JT, Bauer DC, Black DM, Brown TD, Cheung AM, Cody K, Cooper C, Diez-Perez A, Eastell R, Hadji P, Hosoi T, Jan De Beur S, Kagan R, Kiel DP, Reid IR, Solomon DH, Randall S. PMID: 27864889.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    52. Overlapping Surgery in the Ambulatory Orthopaedic Setting. J Bone Joint Surg Am. 2016 Nov 16; 98(22):1859-1867. Zhang AL, Sing DC, Dang DY, Ma CB, Black D, Vail TP, Feeley BT. PMID: 27852902; PMCID: PMC5125164.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    53. Effects of Abaloparatide-SC on Fractures and Bone Mineral Density in Subgroups of Postmenopausal Women With Osteoporosis and Varying Baseline Risk Factors. J Bone Miner Res. 2017 01; 32(1):17-23. Cosman F, Hattersley G, Hu MY, Williams GC, Fitzpatrick LA, Black DM. PMID: 27612281.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    54. Prevalence of osteoporosis in the Italian population and main risk factors: results of BoneTour Campaign. BMC Musculoskelet Disord. 2016 09 17; 17(1):396. Cavalli L, Guazzini A, Cianferotti L, Parri S, Cavalli T, Metozzi A, Giusti F, Fossi C, Black DM, Brandi ML. PMID: 27639376; PMCID: PMC5027125.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    55. Early Cumulative Supplemental Oxygen Predicts Bronchopulmonary Dysplasia in High Risk Extremely Low Gestational Age Newborns. J Pediatr. 2016 Oct; 177:97-102.e2. Wai KC, Kohn MA, Ballard RA, Truog WE, Black DM, Asselin JM, Ballard PL, Rogers EE, Keller RL, Trial of Late Surfactant (TOLSURF) Study Group. PMID: 27470692; PMCID: PMC5037007.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    56. Serum 25-hydroxyvitamin D level and incident type 2 diabetes in older men, the Osteoporotic Fractures in Men (MrOS) study. Bone. 2016 09; 90:181-4. Napoli N, Schafer AL, Lui LY, Cauley JA, Strotmeyer ES, Le Blanc ES, Hoffman AR, Lee CG, Black DM, Schwartz AV. PMID: 27393241; PMCID: PMC5466880.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    57. Postmenopausal Osteoporosis. N Engl J Med. 2016 05 26; 374(21):2096-7. Black DM, Rosen CJ. PMID: 27223157.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    58. Association of 3D Geometric Measures Derived From Quantitative Computed Tomography With Hip Fracture Risk in Older Men. J Bone Miner Res. 2016 08; 31(8):1550-8. Borggrefe J, de Buhr T, Shrestha S, Marshall LM, Orwoll E, Peters K, Black DM, Glüer CC, Osteoporotic Fractures in Men (MrOS) Study Research Group. PMID: 26916713; PMCID: PMC7676812.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    59. Estimating the Time to Benefit for Preventive Drugs with the Statistical Process Control Method: An Example with Alendronate. Drugs Aging. 2016 May; 33(5):347-53. van de Glind EM, Willems HC, Eslami S, Abu-Hanna A, Lems WF, Hooft L, de Rooij SE, Black DM, van Munster BC. PMID: 26884390; PMCID: PMC4837200.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    60. Potential Usefulness of BMD and Bone Turnover Monitoring of Zoledronic Acid Therapy Among Women With Osteoporosis: Secondary Analysis of Randomized Controlled Trial Data. J Bone Miner Res. 2016 09; 31(9):1767-73. Bell KJ, Hayen A, Glasziou P, Irwig L, Eastell R, Harrison SL, Black DM, Bauer DC. PMID: 27027655.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    61. What Proportion of Incident Radiographic Vertebral Fractures in Older Men Is Clinically Diagnosed and Vice Versa: A Prospective Study. J Bone Miner Res. 2016 08; 31(8):1500-3. Ensrud KE, Blackwell TL, Fink HA, Zhang J, Cauley JA, Cawthon PM, Black DM, Bauer DC, Curtis JR, Orwoll ES, Barrett-Connor E, Kado DM, Marshall LM, Shikany JM, Schousboe JT, Osteoporotic Fractures in Men (MrOS) Research Group. PMID: 26969847; PMCID: PMC5065098.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    62. Vitamin D Supplementation and Increased Risk of Falling: A Cautionary Tale of Vitamin Supplements Retold. JAMA Intern Med. 2016 Feb; 176(2):171-2. Cummings SR, Kiel DP, Black DM. PMID: 26746474.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    63. Clinical Practice. Postmenopausal Osteoporosis. N Engl J Med. 2016 Jan 21; 374(3):254-62. Black DM, Rosen CJ. PMID: 26789873.
      View in: PubMed   Mentions: 463     Fields:    Translation:Humans
    64. Sex hormones, sex hormone binding globulin, and vertebral fractures in older men. Bone. 2016 Mar; 84:271-278. Cawthon PM, Schousboe JT, Harrison SL, Ensrud KE, Black D, Cauley JA, Cummings SR, LeBlanc ES, Laughlin GA, Nielson CM, Broughton A, Kado DM, Hoffman AR, Jamal SA, Barrett-Connor E, Orwoll ES, Osteoporotic Fractures in Men (MrOS) Study Research Group. PMID: 26778261; PMCID: PMC4755786.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    65. Pharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study. Physiol Genomics. 2016 Jan; 48(1):33-41. Miller VM, Jenkins GD, Biernacka JM, Heit JA, Huggins GS, Hodis HN, Budoff MJ, Lobo RA, Taylor HS, Manson JE, Black DM, Naftolin F, Harman SM, de Andrade M. PMID: 26508701; PMCID: PMC4757027.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    66. Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide. J Pediatr. 2016 Jan; 168:23-29.e4. Ballard RA, Keller RL, Black DM, Ballard PL, Merrill JD, Eichenwald EC, Truog WE, Mammel MC, Steinhorn RH, Rogers EE, Ryan RM, Durand DJ, Asselin JM, Bendel CM, Bendel-Stenzel EM, Courtney SE, Dhanireddy R, Hudak ML, Koch FR, Mayock DE, McKay VJ, O'Shea TM, Porta NF, Wadhawan R, Palermo L, TOLSURF Study Group. PMID: 26500107; PMCID: PMC4698022.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    67. Degree of Trauma Differs for Major Osteoporotic Fracture Events in Older Men Versus Older Women. J Bone Miner Res. 2016 Jan; 31(1):204-7. Ensrud KE, Blackwell TL, Cawthon PM, Bauer DC, Fink HA, Schousboe JT, Black DM, Orwoll ES, Kado DM, Cauley JA, Mackey DC, Osteoporotic Fractures in Men (MrOS) Study of Osteoporotic Fractures (SOF) Research Groups. PMID: 26178795; PMCID: PMC4730881.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    68. Predicting Hip Fracture Type With Cortical Bone Mapping (CBM) in the Osteoporotic Fractures in Men (MrOS) Study. J Bone Miner Res. 2015 Nov; 30(11):2067-77. Treece GM, Gee AH, Tonkin C, Ewing SK, Cawthon PM, Black DM, Poole KE, Osteoporotic Fractures in Men (MrOS) Study. PMID: 25982802; PMCID: PMC4657505.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    69. Abdominal aortic calcification and risk of fracture among older women - The SOF study. Bone. 2015 Dec; 81:16-23. Szulc P, Blackwell T, Kiel DP, Schousboe JT, Cauley J, Hillier T, Hochberg M, Rodondi N, Taylor BC, Black D, Cummings S, Ensrud KE, Study of Osteoporotic Fractures (SOF) Research Group. PMID: 26115911; PMCID: PMC4640997.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    70. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study. PLoS Med. 2015 Jun; 12(6):e1001833; discussion e1001833. Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, Brinton EA, Cedars MI, Lobo RA, Merriam GR, Neal-Perry G, Santoro NF, Taylor HS, Black DM, Budoff MJ, Hodis HN, Naftolin F, Harman SM, Asthana S. PMID: 26035291; PMCID: PMC4452757.
      View in: PubMed   Mentions: 151     Fields:    Translation:Humans
    71. Intestinal Calcium Absorption Decreases Dramatically After Gastric Bypass Surgery Despite Optimization of Vitamin D Status. J Bone Miner Res. 2015 Aug; 30(8):1377-85. Schafer AL, Weaver CM, Black DM, Wheeler AL, Chang H, Szefc GV, Stewart L, Rogers SJ, Carter JT, Posselt AM, Shoback DM, Sellmeyer DE. PMID: 25640580; PMCID: PMC4593653.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCTClinical Trials
    72. The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res. 2015 May; 30(5):934-44. Black DM, Reid IR, Cauley JA, Cosman F, Leung PC, Lakatos P, Lippuner K, Cummings SR, Hue TF, Mukhopadhyay A, Tan M, Aftring RP, Eastell R. PMID: 25545380.
      View in: PubMed   Mentions: 73     Fields:    Translation:Humans
    73. Relationship between pretreatment rate of bone loss and bone density response to once-yearly ZOL: HORIZON-PFT extension study. J Bone Miner Res. 2015 Mar; 30(3):570-4. Eastell R, Boonen S, Cosman F, Reid IR, Palermo L, Cummings SR, Black DM. PMID: 25214069.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    74. Response to BONE-D-14-00884. Bone. 2015 Jun; 75:246. Cawthon PM, Haslam J, Fullman R, Peters KW, Black D, Ensrud KE, Cummings SR, Orwoll ES, Barrett-Connor E, Marshall L, Steiger P, Schousboe JT, Osteoporotic Fractures in Men (MrOS) Research Group. PMID: 25481408.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    75. Prediction of incident hip fracture with the estimated femoral strength by finite element analysis of DXA Scans in the study of osteoporotic fractures. J Bone Miner Res. 2014 Dec; 29(12):2594-600. Yang L, Palermo L, Black DM, Eastell R. PMID: 24898426; PMCID: PMC4388249.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    76. Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment? J Clin Endocrinol Metab. 2014 Dec; 99(12):4546-54. Cosman F, Cauley JA, Eastell R, Boonen S, Palermo L, Reid IR, Cummings SR, Black DM. PMID: 25215556.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    77. Effect of bisphosphonate use on risk of postmenopausal breast cancer: results from the randomized clinical trials of alendronate and zoledronic acid. JAMA Intern Med. 2014 Oct; 174(10):1550-7. Hue TF, Cummings SR, Cauley JA, Bauer DC, Ensrud KE, Barrett-Connor E, Black DM. PMID: 25111880; PMCID: PMC4398333.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    78. Physical performance and radiographic and clinical vertebral fractures in older men. J Bone Miner Res. 2014 Sep; 29(9):2101-8. Cawthon PM, Blackwell TL, Marshall LM, Fink HA, Kado DM, Ensrud KE, Cauley JA, Black D, Orwoll ES, Cummings SR, Schousboe JT, Osteoporotic Fractures in Men (MrOS) Research Group. PMID: 25042072; PMCID: PMC4335673.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    79. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med. 2014 Aug 19; 161(4):249-60. Harman SM, Black DM, Naftolin F, Brinton EA, Budoff MJ, Cedars MI, Hopkins PN, Lobo RA, Manson JE, Merriam GR, Miller VM, Neal-Perry G, Santoro N, Taylor HS, Vittinghoff E, Yan M, Hodis HN. PMID: 25069991.
      View in: PubMed   Mentions: 107     Fields:    Translation:Humans
    80. A model of BMD changes after alendronate discontinuation to guide postalendronate BMD monitoring. J Clin Endocrinol Metab. 2014 Nov; 99(11):4094-100. McNabb B, Vittinghoff E, Eastell R, Schwartz AV, Bauer DC, Ensrud K, Barrett-Connor E, Black DM. PMID: 25127011; PMCID: PMC5393504.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    81. Methods and reliability of radiographic vertebral fracture detection in older men: the osteoporotic fractures in men study. Bone. 2014 Oct; 67:152-5. Cawthon PM, Haslam J, Fullman R, Peters KW, Black D, Ensrud KE, Cummings SR, Orwoll ES, Barrett-Connor E, Marshall L, Steiger P, Schousboe JT, Osteoporotic Fractures in Men (MrOS) Research Group. PMID: 25003811; PMCID: PMC4152008.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    82. Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study. JAMA Intern Med. 2014 Jul; 174(7):1126-34. Bauer DC, Schwartz A, Palermo L, Cauley J, Hochberg M, Santora A, Cummings SR, Black DM. PMID: 24798675; PMCID: PMC4409325.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    83. Inhaled nitric oxide increases urinary nitric oxide metabolites and cyclic guanosine monophosphate in premature infants: relationship to pulmonary outcome. Am J Perinatol. 2015 Feb; 32(3):225-32. Ballard PL, Keller RL, Black DM, Durand DJ, Merrill JD, Eichenwald EC, Truog WE, Mammel MC, Steinhorn R, Ryan RM, Courtney SE, Horneman H, Ballard RA, Investigators of TOLSURF Pilot and TOLSURF. PMID: 24968129; PMCID: PMC5032843.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    84. Fracture risk in diabetic elderly men: the MrOS study. Diabetologia. 2014 Oct; 57(10):2057-65. Napoli N, Strotmeyer ES, Ensrud KE, Sellmeyer DE, Bauer DC, Hoffman AR, Dam TT, Barrett-Connor E, Palermo L, Orwoll ES, Cummings SR, Black DM, Schwartz AV. PMID: 24908567; PMCID: PMC4344350.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    85. High hip fracture risk in men with severe aortic calcification: MrOS study. J Bone Miner Res. 2014 Apr; 29(4):968-75. Szulc P, Blackwell T, Schousboe JT, Bauer DC, Cawthon P, Lane NE, Cummings SR, Orwoll ES, Black DM, Ensrud KE. PMID: 23983224; PMCID: PMC3935989.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    86. Prediction models of prevalent radiographic vertebral fractures among older women. J Clin Densitom. 2014 Jul-Sep; 17(3):378-85. Schousboe JT, Rosen HR, Vokes TJ, Cauley JA, Cummings SR, Nevitt M, Black DM, Orwoll ES, Kado DM, Ensrud KE, Study of Osteoporotic Fractures Research Group. PMID: 24582085; PMCID: PMC4119570.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    87. The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition. J Alzheimers Dis. 2014; 40(2):331-41. Wharton W, Gleason CE, Dowling NM, Carlsson CM, Brinton EA, Santoro MN, Neal-Perry G, Taylor H, Naftolin F, Lobo RA, Merriam G, Manson JE, Cedars MI, Miller VM, Black DM, Budoff M, Hodis HN, Harman SM, Asthana S. PMID: 24430001; PMCID: PMC4367860.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    88. Prediction models of prevalent radiographic vertebral fractures among older men. J Clin Densitom. 2014 Oct-Dec; 17(4):449-57. Schousboe JT, Rosen HR, Vokes TJ, Cauley JA, Cummings SR, Nevitt MC, Black DM, Orwoll ES, Kado DM, Ensrud KE, Osteoporotic Fractures in Men (MrOS) Study Research Group. PMID: 24289883; PMCID: PMC4035457.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    89. The search for the optimal anabolic osteoporosis therapy. J Bone Miner Res. 2013 Nov; 28(11):2263-5. Black DM, Schafer AL. PMID: 24115189.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    90. Effects of antiresorptive therapies on glucose metabolism: results from the FIT, HORIZON-PFT, and FREEDOM trials. J Bone Miner Res. 2013 Jun; 28(6):1348-54. Schwartz AV, Schafer AL, Grey A, Vittinghoff E, Palermo L, Lui LY, Wallace RB, Cummings SR, Black DM, Bauer DC, Reid IR. PMID: 23322676.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimals
    91. BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronate. J Bone Miner Res. 2013 Jun; 28(6):1319-27. McNabb BL, Vittinghoff E, Schwartz AV, Eastell R, Bauer DC, Ensrud K, Rosenberg E, Santora A, Barrett-Connor E, Black DM. PMID: 23408577.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    92. Diabetes and change in bone mineral density at the hip, calcaneus, spine, and radius in older women. Front Endocrinol (Lausanne). 2013; 4:62. Schwartz AV, Ewing SK, Porzig AM, McCulloch CE, Resnick HE, Hillier TA, Ensrud KE, Black DM, Nevitt MC, Cummings SR, Sellmeyer DE. PMID: 23755040; PMCID: PMC3667237.
      View in: PubMed   Mentions: 22     Fields:    
    93. Risk factors for subtrochanteric and diaphyseal fractures: the study of osteoporotic fractures. J Clin Endocrinol Metab. 2013 Feb; 98(2):659-67. Napoli N, Schwartz AV, Palermo L, Jin JJ, Wustrack R, Cauley JA, Ensrud KE, Kelly M, Black DM. PMID: 23345099; PMCID: PMC3565107.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    94. Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS). Fertil Steril. 2013 Apr; 99(5):1385-91. Wolff EF, He Y, Black DM, Brinton EA, Budoff MJ, Cedars MI, Hodis HN, Lobo RA, Manson JE, Merriam GR, Miller VM, Naftolin F, Pal L, Santoro N, Zhang H, Harman SM, Taylor HS. PMID: 23312232; PMCID: PMC3615128.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    95. Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study. Pediatr Res. 2012 Dec; 72(6):613-9. Keller RL, Merrill JD, Black DM, Steinhorn RH, Eichenwald EC, Durand DJ, Ryan RM, Truog WE, Courtney SE, Ballard PL, Ballard RA. PMID: 23037875; PMCID: PMC3548137.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    96. Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res. 2012 Aug; 27(8):1627-34. Jacques RM, Boonen S, Cosman F, Reid IR, Bauer DC, Black DM, Eastell R. PMID: 22532515.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    97. Six months of parathyroid Hormone (1-84) administered concurrently versus sequentially with monthly ibandronate over two years: the PTH and ibandronate combination study (PICS) randomized trial. J Clin Endocrinol Metab. 2012 Oct; 97(10):3522-9. Schafer AL, Sellmeyer DE, Palermo L, Hietpas J, Eastell R, Shoback DM, Black DM. PMID: 22791766; PMCID: PMC3674294.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    98. Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis. J Bone Miner Res. 2012 Jul; 27(7):1487-93. Boonen S, Eastell R, Su G, Mesenbrink P, Cosman F, Cauley JA, Reid IR, Claessens F, Vanderschueren D, Lyles KW, Black DM. PMID: 22431413; PMCID: PMC3636532.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    99. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev. 2012 Jun; 33(3):456-92. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, Murad MH, Kovacs CS. PMID: 22596255; PMCID: PMC3365859.
      View in: PubMed   Mentions: 255     Fields:    Translation:HumansAnimals
    100. Continuing bisphosphonate treatment for osteoporosis--for whom and for how long? N Engl J Med. 2012 May 31; 366(22):2051-3. Black DM, Bauer DC, Schwartz AV, Cummings SR, Rosen CJ. PMID: 22571169; PMCID: PMC4015798.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    101. Incidence and demography of femur fractures with and without atypical features. J Bone Miner Res. 2012 May; 27(5):977-86. Feldstein AC, Black D, Perrin N, Rosales AG, Friess D, Boardman D, Dell R, Santora A, Chandler JM, Rix MM, Orwoll E. PMID: 22275107.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    102. Are women with thicker cortices in the femoral shaft at higher risk of subtrochanteric/diaphyseal fractures? The study of osteoporotic fractures. J Clin Endocrinol Metab. 2012 Jul; 97(7):2414-22. Napoli N, Jin J, Peters K, Wustrack R, Burch S, Chau A, Cauley J, Ensrud K, Kelly M, Black DM. PMID: 22547423; PMCID: PMC3387394.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    103. Following the bone density trail: a clinical perspective. J Clin Endocrinol Metab. 2012 Apr; 97(4):1176-8. Black DM, Rosen CJ. PMID: 22493309.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    104. Prediction of new clinical vertebral fractures in elderly men using finite element analysis of CT scans. J Bone Miner Res. 2012 Apr; 27(4):808-16. Wang X, Sanyal A, Cawthon PM, Palermo L, Jekir M, Christensen J, Ensrud KE, Cummings SR, Orwoll E, Black DM, Osteoporotic Fractures in Men (MrOS) Research Group, Keaveny TM. PMID: 22190331; PMCID: PMC3510751.
      View in: PubMed   Mentions: 89     Fields:    Translation:Humans
    105. The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res. 2012 Feb; 27(2):243-54. Black DM, Reid IR, Boonen S, Bucci-Rechtweg C, Cauley JA, Cosman F, Cummings SR, Hue TF, Lippuner K, Lakatos P, Leung PC, Man Z, Martinez RL, Tan M, Ruzycky ME, Su G, Eastell R. PMID: 22161728; PMCID: PMC3427916.
      View in: PubMed   Mentions: 159     Fields:    Translation:Humans
    106. Height loss in older women: risk of hip fracture and mortality independent of vertebral fractures. J Bone Miner Res. 2012 Jan; 27(1):153-9. Hillier TA, Lui LY, Kado DM, LeBlanc ES, Vesco KK, Bauer DC, Cauley JA, Ensrud KE, Black DM, Hochberg MC, Cummings SR. PMID: 22072593; PMCID: PMC3622730.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    107. Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study). J Clin Endocrinol Metab. 2011 Dec; 96(12):E1982-9. Schafer AL, Sellmeyer DE, Schwartz AV, Rosen CJ, Vittinghoff E, Palermo L, Bilezikian JP, Shoback DM, Black DM. PMID: 21994958; PMCID: PMC3232610.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    108. Effects of antiresorptive treatment on nonvertebral fracture outcomes. J Bone Miner Res. 2011 Oct; 26(10):2411-8. Mackey DC, Black DM, Bauer DC, McCloskey EV, Eastell R, Mesenbrink P, Thompson JR, Cummings SR. PMID: 21710615.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    109. Hip fracture and increased short-term but not long-term mortality in healthy older women. Arch Intern Med. 2011 Nov 14; 171(20):1831-7. LeBlanc ES, Hillier TA, Pedula KL, Rizzo JH, Cawthon PM, Fink HA, Cauley JA, Bauer DC, Black DM, Cummings SR, Browner WS. PMID: 21949033; PMCID: PMC3576923.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    110. WHO absolute fracture risk models (FRAX): do clinical risk factors improve fracture prediction in older women without osteoporosis? J Bone Miner Res. 2011 Aug; 26(8):1774-82. Hillier TA, Cauley JA, Rizzo JH, Pedula KL, Ensrud KE, Bauer DC, Lui LY, Vesco KK, Black DM, Donaldson MG, Leblanc ES, Cummings SR. PMID: 21351144; PMCID: PMC3622725.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    111. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011 Jun 01; 305(21):2184-92. Schwartz AV, Vittinghoff E, Bauer DC, Hillier TA, Strotmeyer ES, Ensrud KE, Donaldson MG, Cauley JA, Harris TB, Koster A, Womack CR, Palermo L, Black DM, Study of Osteoporotic Fractures (SOF) Research Group, Osteoporotic Fractures in Men (MrOS) Research Group, Health, Aging, and Body Composition (Health ABC) Research Group. PMID: 21632482; PMCID: PMC3287389.
      View in: PubMed   Mentions: 267     Fields:    Translation:Humans
    112. Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial. J Bone Miner Res. 2011 May; 26(5):984-92. Cauley JA, Black D, Boonen S, Cummings SR, Mesenbrink P, Palermo L, Man Z, Hadji P, Reid IR, HORIZON Pivotal Fracture Group. PMID: 21542001; PMCID: PMC5104553.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    113. Quantification of vertebral bone marrow fat content using 3 Tesla MR spectroscopy: reproducibility, vertebral variation, and applications in osteoporosis. J Magn Reson Imaging. 2011 Apr; 33(4):974-9. Li X, Kuo D, Schafer AL, Porzig A, Link TM, Black D, Schwartz AV. PMID: 21448966; PMCID: PMC3072841.
      View in: PubMed   Mentions: 76     Fields:    Translation:Humans
    114. The relationship between bisphosphonate adherence and fracture: is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial. J Bone Miner Res. 2011 Apr; 26(4):683-8. Curtis JR, Delzell E, Chen L, Black D, Ensrud K, Judd S, Safford MM, Schwartz AV, Bauer DC. PMID: 20939064; PMCID: PMC3179329.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    115. Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy. J Clin Endocrinol Metab. 2011 Jun; 96(6):1627-32. Gomberg SJ, Wustrack RL, Napoli N, Arnaud CD, Black DM. PMID: 21430030.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    116. Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFT. Bone. 2011 Jun 01; 48(6):1298-304. Sambrook PN, Silverman SL, Cauley JA, Recknor C, Olson M, Su G, Boonen S, Black D, Adachi JD, HORIZON Pivotal Fracture Trial. PMID: 21421092.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    117. Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med. 2011 Mar; 124(3):199-205. Harman SM, Vittinghoff E, Brinton EA, Budoff MJ, Cedars MI, Lobo RA, Merriam GR, Miller VM, Naftolin F, Pal L, Santoro N, Taylor HS, Black DM. PMID: 21396500; PMCID: PMC3107840.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    118. Increasing kyphosis predicts worsening mobility in older community-dwelling women: a prospective cohort study. J Am Geriatr Soc. 2011 Jan; 59(1):96-100. Katzman WB, Vittinghoff E, Ensrud K, Black DM, Kado DM. PMID: 21198460; PMCID: PMC3696343.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    119. Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid. J Bone Miner Res. 2011 Jan; 26(1):12-8. Gamsjaeger S, Buchinger B, Zwettler E, Recker R, Black D, Gasser JA, Eriksen EF, Klaushofer K, Paschalis EP. PMID: 20645415.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    120. Consistency of bone turnover marker and calcium responses to parathyroid hormone (1-84) therapy in postmenopausal osteoporosis. J Clin Densitom. 2011 Jan-Mar; 14(1):68-73. Schafer AL, Palermo L, Bauer DC, Bilezikian JP, Sellmeyer DE, Black DM. PMID: 21095149.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    121. The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program. J Am Dent Assoc. 2010 Nov; 141(11):1365-70. Grbic JT, Black DM, Lyles KW, Reid DM, Orwoll E, McClung M, Bucci-Rechtweg C, Su G. PMID: 21037195.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCTClinical Trials
    122. Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation guidelines. J Bone Miner Res. 2010 Jul; 25(7):1506-11. Donaldson MG, Cawthon PM, Lui LY, Schousboe JT, Ensrud KE, Taylor BC, Cauley JA, Hillier TA, Dam TT, Curtis JR, Black DM, Bauer DC, Orwoll ES, Cummings SR, Osteoporotic Fractures in Men (MrOS) Study Group. PMID: 20200971; PMCID: PMC3153995.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    123. Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial. J Bone Miner Res. 2010 May; 25(5):976-82. Schwartz AV, Bauer DC, Cummings SR, Cauley JA, Ensrud KE, Palermo L, Wallace RB, Hochberg MC, Feldstein AC, Lombardi A, Black DM, FLEX Research Group. PMID: 20200926.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    124. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010 May 13; 362(19):1761-71. Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, Leung PC, Boonen S, Santora A, de Papp A, Bauer DC, Fracture Intervention Trial Steering Committee, HORIZON Pivotal Fracture Trial Steering Committee. PMID: 20335571.
      View in: PubMed   Mentions: 142     Fields:    Translation:Humans
    125. Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older. J Am Geriatr Soc. 2010 Feb; 58(2):292-9. Boonen S, Black DM, Colón-Emeric CS, Eastell R, Magaziner JS, Eriksen EF, Mesenbrink P, Haentjens P, Lyles KW. PMID: 20070415; PMCID: PMC3660706.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    126. Accounting for multiple births in neonatal and perinatal trials: systematic review and case study. J Pediatr. 2010 Feb; 156(2):202-8. Hibbs AM, Black D, Palermo L, Cnaan A, Luan X, Truog WE, Walsh MC, Ballard RA. PMID: 19969305; PMCID: PMC2844328.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    127. Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation. Pediatrics. 2009 Nov; 124(5):1325-32. Zupancic JA, Hibbs AM, Palermo L, Truog WE, Cnaan A, Black DM, Ballard PL, Wadlinger SR, Ballard RA, NO CLD Trial Group. PMID: 19841125.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    128. Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis. J Bone Miner Res. 2009 Sep; 24(9):1544-51. Delmas PD, Munoz F, Black DM, Cosman F, Boonen S, Watts NB, Kendler D, Eriksen EF, Mesenbrink PG, Eastell R, HORIZON-PFT Research Group. PMID: 19338427.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    129. Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. J Clin Endocrinol Metab. 2009 Sep; 94(9):3215-25. Eastell R, Black DM, Boonen S, Adami S, Felsenberg D, Lippuner K, Cummings SR, Delmas PD, Palermo L, Mesenbrink P, Cauley JA, HORIZON Pivotal Fracture Trial. PMID: 19567517; PMCID: PMC5101059.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    130. Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab. 2009 Jul; 94(7):2380-6. Schwartz AV, Garnero P, Hillier TA, Sellmeyer DE, Strotmeyer ES, Feingold KR, Resnick HE, Tylavsky FA, Black DM, Cummings SR, Harris TB, Bauer DC, Health, Aging, and Body Composition Study. PMID: 19383780; PMCID: PMC2708944.
      View in: PubMed   Mentions: 118     Fields:    Translation:Humans
    131. Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines. J Bone Miner Res. 2009 Apr; 24(4):675-80. Donaldson MG, Cawthon PM, Lui LY, Schousboe JT, Ensrud KE, Taylor BC, Cauley JA, Hillier TA, Black DM, Bauer DC, Cummings SR, Study of Osteoporotic Fractures. PMID: 19049330; PMCID: PMC2659514.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    132. Teriparatide vertebral fracture risk reduction determined by quantitative and qualitative radiographic assessment. Curr Med Res Opin. 2009 Apr; 25(4):921-8. Prevrhal S, Krege JH, Chen P, Genant H, Black DM. PMID: 19250060.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    133. Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United States. J Bone Miner Res. 2009 Mar; 24(3):389-97. Glover SJ, Gall M, Schoenborn-Kellenberger O, Wagener M, Garnero P, Boonen S, Cauley JA, Black DM, Delmas PD, Eastell R. PMID: 18665786.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    134. Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans. J Bone Miner Res. 2008 Dec; 23(12):1974-82. Keaveny TM, Hoffmann PF, Singh M, Palermo L, Bilezikian JP, Greenspan SL, Black DM. PMID: 18684084; PMCID: PMC2686921.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    135. Prevalent vertebral fractures in black women and white women. J Bone Miner Res. 2008 Sep; 23(9):1458-67. Cauley JA, Palermo L, Vogt M, Ensrud KE, Ewing S, Hochberg M, Nevitt MC, Black DM. PMID: 18442309; PMCID: PMC2683160.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    136. Effects of PTH and alendronate on type I collagen isomerization in postmenopausal women with osteoporosis: the PaTH study. J Bone Miner Res. 2008 Sep; 23(9):1442-8. Garnero P, Bauer DC, Mareau E, Bilezikian JP, Greenspan SL, Rosen C, Black D. PMID: 18442311; PMCID: PMC2683159.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    137. Proximal femoral structure and the prediction of hip fracture in men: a large prospective study using QCT. J Bone Miner Res. 2008 Aug; 23(8):1326-33. Black DM, Bouxsein ML, Marshall LM, Cummings SR, Lang TF, Cauley JA, Ensrud KE, Nielson CM, Orwoll ES, Osteoporotic Fractures in Men (MrOS) Research Group. PMID: 18348697; PMCID: PMC2680175.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    138. Review of comparative effectiveness of treatments to prevent fractures. Ann Intern Med. 2008 Jun 03; 148(11):885-6; author reply 887. Black DM, Boonen S, Delmas P, Lyles KW. PMID: 18519940.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    139. Inhaled nitric oxide for preterm infants. Pediatrics. 2008 Jun; 121(6):1287-8; author reply 1288-9. Truog WE, Martin RJ, Ballard RA, Black D, Cnaan A, NO CLD Study Group. PMID: 18519502.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    140. Randomized trial of once-weekly parathyroid hormone (1-84) on bone mineral density and remodeling. J Clin Endocrinol Metab. 2008 Jun; 93(6):2166-72. Black DM, Bouxsein ML, Palermo L, McGowan JA, Newitt DC, Rosen E, Majumdar S, Rosen CJ, PTH Once-Weekly Research (POWR) Group. PMID: 18349061; PMCID: PMC2435646.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    141. Comparison of DXA hip structural analysis with volumetric QCT. J Clin Densitom. 2008 Apr-Jun; 11(2):232-6. Prevrhal S, Shepherd JA, Faulkner KG, Gaither KW, Black DM, Lang TF. PMID: 18280192.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    142. Identification of vertebral fracture and non-osteoporotic short vertebral height in men: the MrOS study. J Bone Miner Res. 2007 Sep; 22(9):1434-41. Ferrar L, Jiang G, Cawthon PM, San Valentin R, Fullman R, Lambert L, Cummings SR, Black DM, Orwoll E, Barrett-Connor E, Ensrud K, Fink HA, Eastell R, Osteoporotic Fractures in Men (MrOS) Study. PMID: 17563237.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    143. Is risedronate or alendronate more effective at preventing nonvertebral fractures in women with osteoporosis? Nat Clin Pract Rheumatol. 2007 Jul; 3(7):378-9. Black DM, Rosen CJ. PMID: 17549088.
      View in: PubMed   Mentions: 1     Fields:    
    144. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007 May 03; 356(18):1809-22. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR, HORIZON Pivotal Fracture Trial. PMID: 17476007.
      View in: PubMed   Mentions: 809     Fields:    Translation:Humans
    145. Alendronate and atrial fibrillation. N Engl J Med. 2007 May 03; 356(18):1895-6. Cummings SR, Schwartz AV, Black DM. PMID: 17476024.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    146. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA. 2006 Dec 27; 296(24):2927-38. Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR, FLEX Research Group. PMID: 17190893.
      View in: PubMed   Mentions: 406     Fields:    Translation:Humans
    147. Elevations in serum and urinary calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosis. J Clin Endocrinol Metab. 2007 Mar; 92(3):942-7. Antoniucci DM, Sellmeyer DE, Bilezikian JP, Palermo L, Ensrud KE, Greenspan SL, Black DM. PMID: 17164314; PMCID: PMC3746103.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    148. Primary sclerosing cholangitis: summary of a workshop. Hepatology. 2006 Sep; 44(3):746-64. LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E, Hoofnagle JH. PMID: 16941705.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    149. The effects of organic nitrates on osteoporosis: a randomized controlled trial [ISRCTN94484747]. Trials. 2006 Apr 26; 7:10. Jamal SA, Hamilton CJ, Black D, Cummings SR. PMID: 16640783; PMCID: PMC1471803.
      View in: PubMed   Mentions: 5     Fields:    
    150. Developing better economic models of osteoporosis: considerations for the calculation of the relative risk of fracture. Value Health. 2006 Jan-Feb; 9(1):54-8. Black DM, Palermo L, Grima DT. PMID: 16441525.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    151. Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial. J Bone Miner Res. 2006 Feb; 21(2):292-9. Bauer DC, Garnero P, Hochberg MC, Santora A, Delmas P, Ewing SK, Black DM, Fracture Intervention Research Group. PMID: 16418785.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    152. One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. N Engl J Med. 2005 Aug 11; 353(6):555-65. Black DM, Bilezikian JP, Ensrud KE, Greenspan SL, Palermo L, Hue T, Lang TF, McGowan JA, Rosen CJ, PaTH Study Investigators. PMID: 16093464.
      View in: PubMed   Mentions: 179     Fields:    Translation:HumansCTClinical Trials
    153. Vitamin D insufficiency does not affect bone mineral density response to raloxifene. J Clin Endocrinol Metab. 2005 Aug; 90(8):4566-72. Antoniucci DM, Vittinghoff E, Blackwell T, Black DM, Sellmeyer DE. PMID: 15899959.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    154. What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa? J Bone Miner Res. 2005 Jul; 20(7):1216-22. Fink HA, Milavetz DL, Palermo L, Nevitt MC, Cauley JA, Genant HK, Black DM, Ensrud KE, Fracture Intervention Trial Research Group. PMID: 15940375.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    155. Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of-1.6 to -2.5 at the femoral neck: the Fracture Intervention Trial. Mayo Clin Proc. 2005 Mar; 80(3):343-9. Quandt SA, Thompson DE, Schneider DL, Nevitt MC, Black DM, Fracture Intervention Trial Research Group. PMID: 15757015.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    156. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab. 2005 May; 90(5):2787-93. Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, Hochberg MC, Vogt MT, Orwoll ES, Study of Osteoporotic Fractures Research Group. PMID: 15728213.
      View in: PubMed   Mentions: 205     Fields:    Translation:Humans
    157. Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures. J Bone Miner Res. 2005 Jun; 20(6):971-6. Hochberg MC, Thompson DE, Black DM, Quandt SA, Cauley J, Geusens P, Ross PD, Baran D, FIT Research Group. PMID: 15883637.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    158. Serum 25-hydroxyvitamin D is unaffected by multiple freeze-thaw cycles. Clin Chem. 2005 Jan; 51(1):258-61. Antoniucci DM, Black DM, Sellmeyer DE. PMID: 15613728.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    159. Diabetes and bone loss at the hip in older black and white adults. J Bone Miner Res. 2005 Apr; 20(4):596-603. Schwartz AV, Sellmeyer DE, Strotmeyer ES, Tylavsky FA, Feingold KR, Resnick HE, Shorr RI, Nevitt MC, Black DM, Cauley JA, Cummings SR, Harris TB, Health ABC Study. PMID: 15765178.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    160. beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures. J Bone Miner Res. 2005 Apr; 20(4):613-8. Reid IR, Gamble GD, Grey AB, Black DM, Ensrud KE, Browner WS, Bauer DC. PMID: 15765180.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    161. Alternative tree-structured survival analysis based on variance of survival time. Med Decis Making. 2004 Nov-Dec; 24(6):670-80. Jin H, Lu Y, Stone K, Black DM. PMID: 15534347.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    162. Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: the study of osteoporotic fractures. J Bone Miner Res. 2005 Jan; 20(1):131-40. Nevitt MC, Cummings SR, Stone KL, Palermo L, Black DM, Bauer DC, Genant HK, Hochberg MC, Ensrud KE, Hillier TA, Cauley JA. PMID: 15619679.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    163. Classification algorithms for hip fracture prediction based on recursive partitioning methods. Med Decis Making. 2004 Jul-Aug; 24(4):386-98. Jin H, Lu Y, Harris ST, Black DM, Stone K, Hochberg MC, Genant HK. PMID: 15271277.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    164. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. J Bone Miner Res. 2004 Aug; 19(8):1250-8. Bauer DC, Black DM, Garnero P, Hochberg M, Ott S, Orloff J, Thompson DE, Ewing SK, Delmas PD, Fracture Intervention Trial Study Group. PMID: 15231011.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansCTClinical Trials
    165. Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension. J Bone Miner Res. 2004 Aug; 19(8):1259-69. Ensrud KE, Barrett-Connor EL, Schwartz A, Santora AC, Bauer DC, Suryawanshi S, Feldstein A, Haskell WL, Hochberg MC, Torner JC, Lombardi A, Black DM, Fracture Intervention Trial Long-Term Extension Research Group. PMID: 15231012.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansCTClinical Trials
    166. Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study. J Bone Miner Res. 2004 May; 19(5):764-72. Johnell O, Kanis JA, Black DM, Balogh A, Poor G, Sarkar S, Zhou C, Pavo I. PMID: 15068500.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCTClinical Trials
    167. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Arch Intern Med. 2004 Jan 26; 164(2):146-52. Bauer DC, Mundy GR, Jamal SA, Black DM, Cauley JA, Ensrud KE, van der Klift M, Pols HA. PMID: 14744837.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    168. Vignettes in osteoporosis: a road map to successful therapeutics. J Bone Miner Res. 2004 Jan; 19(1):3-10. Rosen CJ, Black DM, Greenspan SL. PMID: 14753730.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    169. Bone mineral density and prevalent vertebral fractures in men and women. Osteoporos Int. 2004 Jan; 15(1):32-7. Cauley JA, Zmuda JM, Wisniewski SR, Krishnaswami S, Palermo L, Stone KL, Black DM, Nevitt MC. PMID: 14628107.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    170. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med. 2003 Sep 25; 349(13):1207-15. Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ, PaTH Study Investigators. PMID: 14500804.
      View in: PubMed   Mentions: 347     Fields:    Translation:HumansCTClinical Trials
    171. Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial. Bone. 2003 Sep; 33(3):293-300. Kanis JA, Johnell O, Black DM, Downs RW, Sarkar S, Fuerst T, Secrest RJ, Pavo I. PMID: 13678769.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCTClinical Trials
    172. Fracture and the risk of coronary events in women with heart disease. Am J Med. 2003 Aug 15; 115(3):196-202. Varosy PD, Shlipak MG, Vittinghoff E, Black DM, Herrington D, Hulley SB, Browner WS, Heart and Estrogen/Progestin Replacement Study(HERS) Investigators. PMID: 12935826.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    173. Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab. 2003 Aug; 88(8):3482-6. Siris ES, Bilezikian JP, Rubin MR, Black DM, Bockman RS, Bone HG, Hochberg MC, McClung MR, Schnitzer TJ. PMID: 12915621.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    174. Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fractures. Pharmacoeconomics. 2003; 21(5):305-14. Johnell O, Jönsson B, Jönsson L, Black D. PMID: 12627984.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    175. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab. 2002 Aug; 87(8):3609-17. Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, Reginster JY, Pols HA, Recker RR, Harris ST, Wu W, Genant HK, Black DM, Eastell R, Mulitple Outcomes of Raloxifene Evaluation Investigators. PMID: 12161484.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansCTClinical Trials
    176. Identifying fracture risk in postmenopausal women. JAMA. 2002 Mar 06; 287(9):1109; author reply 1110. Black D, Wagman RB. PMID: 11879095.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    177. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med. 2002 Mar; 112(4):281-9. Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Black DM. PMID: 11893367.
      View in: PubMed   Mentions: 206     Fields:    Translation:Humans
    178. Alendronate reduces the risk of multiple symptomatic fractures: results from the fracture intervention trial. J Am Geriatr Soc. 2002 Mar; 50(3):409-15. Levis S, Quandt SA, Thompson D, Scott J, Schneider DL, Ross PD, Black D, Suryawanshi S, Hochberg M, Yates J, FIT Research Group. PMID: 11943033.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    179. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res. 2002 Jan; 17(1):1-10. Sarkar S, Mitlak BH, Wong M, Stock JL, Black DM, Harper KD. PMID: 11771654.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansCTClinical Trials
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Dennis's Networks
    Concepts (376)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (58)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.